TITLE:
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.

CONDITION:
Anemia

INTERVENTION:
methoxy polyethylene glycol-epoetin beta [Mircera]

SUMMARY:

      This study will evaluate the efficacy and safety of different subcutaneous starting doses
      and dosing frequencies of Mircera in anemic patients with chronic kidney disease not yet on
      dialysis. The anticipated time on study treatment is 3-12 months and the target sample size
      is <100 individuals.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  adult patients >=18 years of age;

          -  chronic renal anemia;

          -  not receiving renal replacement therapy.

        Exclusion Criteria:

          -  women who are pregnant, breastfeeding or using unreliable birth control methods;

          -  administration of any investigational drug within 30 days preceding the screening
             visit and during the run-in period.
      
